Woods Keith

Woods Keith is listed in filings as Director at TScan Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to TScan Therapeutics, Inc. (TCRX), Scholar Rock Holding Corporation (SRRK), Neurogene Inc. (NGNE), and X4 Pharmaceuticals, Inc. (XFOR). The current snapshot covers public activity from Jun 11, 2024 to May 22, 2026. Reported amounts are shown as $66.6K to $212.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.